Stock Opinions by Geoff Houlton

Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)

All	Rating	Big Win	Win	Neutral	Loss	Big Loss
All	0	0 0.00%	0 0.00%	0 0.00%	0 0.00%	0 0.00%

Latest Top Picks

Unlock Geoff's portfolio

Stock Opinions by Geoff Houlton

TRADE

A drug that corrects complications that occur with the prostrate and prostrate cancer. Entering phase 2 clinical trials, has large market opportunities. Have done safety studies. In good shape regarding their cash position.

BUY

Has raised capital. Produces a hand held company to assist primary care physicians, to help electronic prescribing. It doesn’t cost the physician anything. The company is doing very well.

BUY

Has done tremendously well. They focus on wound care products, and coatings for products. The company has tremendous potential, they signed a deal with a large British company. Great opportunity, going to do well going forward.

BUY

A very interesting company. Has an animal health product, human health products focused on bladder cancer and a vaccine for cattle. Likes the company, has existing products (short-term revenue stream) and has future opportunity and a potential blockbuster product. A significant opportunity.

WEAK BUY

Been around for a long time. Has a broad range of technologies. Have recently signed licensed for Virusmax, which can double the yield of virus production for vaccinations. Bull semen-sexing technology. Have some very interesting technologies. Watching it very closely. Like the company.

TOP PICK

Focuses on providing software for doctors, directed at Primary physicians. Have lots of new products coming through. Great opportunity.

TOP PICK

Recently suffered when phase 3 testing failed. Has cash in the bank, has a long runway (cash on a burn rate). Have 2 products in phase 3, one of which is approved in India and China. Great opportunities. Way undervalued.

Showing 1 to 7 of 7 entries

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Geoff Houlton

Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Stock Opinions by Geoff Houlton

Sophiris Bio(SHS-T)

Zoomed(ZMD-X)

Covalon Technologies(COV-X)

Telesta Therapeutics Inc(TST-T)

Microbix Biosystems(MBX-T)

Healthscreen Solutions Inc.(MDU-X)

YM BioSciences(YM-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Brendan Caldwell

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase Insights

Jim Cramer - Mad Money